glp-1 medicine Weight Loss Options Ease your GLP Glucagon-like peptide-1 - Wikipedia
Description
Statements Author contributions CL: Conceptualization, Formal Analysis, Writing original draft, Writing review & editing
The researchers found that 35 (54 percent) and 40 (62 percent) patients had a 1-point or higher reduction in the HS Physician's Global Assessment and 12 and 32 percent showed a 2-point or higher reduction at six months and at discontinuation or last consultation, respectively
"Ideally, we want patients to lose adipose tissue and preserve their lean body mass
In contrast, AOM semaglutide increased by +0.1 points from June to Julyits largest one-month gain in the study period, compared with an average of just +0.02 points per month previously
Washington, DC: The National Academies Press
